RxDoctor Payments Data

Joseph Bata

Physician Assistant · Rochester Hills, MINPI 1750972113

Payments from drug & device makers

$4,867in general payments, 2019–2025

Across 232 payments — averaging $20.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$558
  • Lilly USA, LLC$442
  • Amgen$297
  • Boehringer Ingelheim$292
  • Bayer$263
  • Corcept Therapeutics$230
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$4,867100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,867 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$1,204
Medicare patients
11
Services billed
11

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide140$254,517
MounjaroTirzepatide83$153,898
JardianceEmpagliflozin85$115,009
FarxigaDapagliflozin Propanediol38$50,973
TrulicityDulaglutide30$47,405
Tresiba Flextouch U-100Insulin Degludec31$25,999
JanuviaSitagliptin Phosphate22$25,225
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog26$22,539
Novolog FlexpenInsulin Aspart65$18,490
Humalog Kwikpen U-100Insulin Lispro45$15,852
Lantus SolostarInsulin Glargine,hum.Rec.Anlog95$13,927
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$13,367
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$12,912
Nano 2nd Gen Pen NeedlePen Needle, Diabetic83$9,030
Insulin Lispro Kwikpen U-100Insulin Lispro14$4,568

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$558$254,517140 claims
Lilly USA, LLCMounjaro, Trulicity$442$201,303113 claims
Boehringer IngelheimJardiance$292$115,00985 claims
MerckJanuvia$44$25,22522 claims
AbbVieSynthroid$183$2,66425 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$169$1,542115 claims
PfizerLevoxyl$67$97530 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →